jp
en
News
Technology
Company
Contact
jp
en
Contact
News
2025.09.11
General
We Are Pleased to Announce That We Will Exhibit at BioJapan 2025, Asia’s Leading Partnering Event for the Global Biotechnology Industry. The Event Will Be Held at PACIFICO Yokohama from October 8 to 10, 2025.
2025.09.03
General
Neusignal Therapeutics Announces Completion of Safety and Tolerability Assessment in a Study of Alzheimer’s Disease Drug Candidate NTX-083 in Healthy Volunteers
2025.06.30
General
Neusignal Therapeutics Announces New CEO
2025.02.18
General
Neusignal Therapeutics Provides Alzheimer’s Disease Treatment Candidate (NTX-083) for Investigator-Initiated Clinical Trial in Healthy Adults at the University of Tokyo Hospital
2025.01.31
IR
Neusignal Therapeutics Raises ¥2.25 Billion in Series A Funding– Plans To Begin Clinical Trials and Strengthen Development Infrastructure for U.S. Expansion
